{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T10:49:02Z","timestamp":1785754142389,"version":"3.56.0"},"reference-count":69,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNSAMC"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Epilepsy is a common disorder of the Central Nervous System (CNS).\nThe rational design of small-molecule drugs for disorders of the CNS is a difficult process because\nthe majority of small molecules are unable to cross the Blood-Brain-Barrier. An efficient method\nfor the design of inhibitors that have high permeability through the Blood-Brain-Barrier has the potential\nfor application in drug design for CNS disorders such as Addiction, Alzheimer\u2019s disease,\nBipolar disorder, Depression, Epilepsy, Gliomas, and Tuberculous meningitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Supervised learning was used to model the Blood-Brain-Barrier permeability of drugs like\nsmall organic molecules. This information was utilized to guide an evolutionary algorithm for the\ndesign of inhibitors with increased affinity for the target as well as higher Blood-Brain-Barrier\npermeability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The ligands designed with guided evolution were predicted to have higher binding affinity\nfor the target as well as higher permeability across the Blood-Brain-Barrier compared to an evolutionary\nalgorithm without the guidance. The guided evolutionary method was applied to design a\nset of drug-like ligands that were predicted to bind to GABA-T with high affinity, to be BBB permeable,\nand to be chemically synthesizable.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>Despite the availability of several drugs that are approved for the treatment of epilepsy,\nthere are many cases that do not respond to available drugs or experience adverse effects. The\nnovel ligands designed as part of this work have the potential to address the limitations of available\ndrugs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Guided evolution is an efficient computational approach for the design of CNS drugs.\nThe de novo design of drugs by application of the guided evolution algorithm, developed as part of\nthis work, has resulted in the generation of ligands that are potential drugs for the cure of epilepsy.\nHowever, the effectiveness of these drugs for the cure of epilepsy has to be validated experimentally.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0118715249385792250709073502","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T11:42:09Z","timestamp":1752579729000},"page":"212-224","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Computational Design of Drugs for Epilepsy using a Novel Guided Evolutionary Algorithm for Enhanced Blood Brain Barrier Permeability"],"prefix":"10.2174","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3394-9795","authenticated-orcid":true,"given":"Sekhar","family":"Talluri","sequence":"first","affiliation":[{"name":"Department of Biotechnology, GITAM School of Technology, GITAM, Visakhapatnam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"6380","DOI":"10.3390\/molecules26216380","volume":"26","author":"Ciccone L.","year":"2021","unstructured":"Ciccone L.; Cerri C.; Nencetti S.; Orlandini E.; Carbonic anhydrase inhibitors and epilepsy: State of the art and future perspectives. Molecules  2021,26(21),6380","journal-title":"Molecules"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2174\/1570159X18666200915151909","volume":"19","author":"Garcia-Rosa S.","year":"2021","unstructured":"Garcia-Rosa S.; de Freitas Brenha B.; da Rocha V.F.; Goulart E.; Silva Araujo B.H.; Personalized medicine using cutting edge technologies for genetic epilepsies. Curr Neuropharmacol  2021,19(6),813-831","journal-title":"Curr Neuropharmacol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.eplepsyres.2006.02.004","volume":"69","author":"Rogawski M.A.","year":"2006","unstructured":"Rogawski M.A.; Diverse mechanisms of antiepileptic drugs in the development pipeline. Epilepsy Res  2006,69(3),273-294","journal-title":"Epilepsy Res"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1528-1167.2007.00992.x","volume":"48","author":"French J.A.","year":"2007","unstructured":"French J.A.; Refractory epilepsy: Clinical overview. Epilepsia  (Suppl. 1)2007,48(S1),3-7","journal-title":"Epilepsia"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3389\/fneur.2017.00301","volume":"8","author":"Tang F.","year":"2017","unstructured":"Tang F.; Hartz A.M.S.; Bauer B.; Drug-resistant epilepsy: Multiple hypotheses, few answers. Front Neurol  2017,8,301","journal-title":"Front Neurol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"925281","DOI":"10.3389\/fchem.2022.925281","volume":"10","author":"Song M.","year":"2022","unstructured":"Song M.; Zhao W.; Zhu Y.; Liu W.; Deng X.; Huang Y.; Design, synthesis, and evaluation of anticonvulsant activities of new triazolopyrimidine derivatives. Front Chem  2022,10,925281","journal-title":"Front Chem"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"616298","DOI":"10.3389\/fnins.2020.616298","volume":"14","author":"Castellano D.","year":"2021","unstructured":"Castellano D.; Shepard R.D.; Lu W.; Looking for novelty in an \u201cold\u201d receptor: Recent advances toward our understanding of GABAARs and their implications in receptor pharmacology. Front Neurosci  2021,14,616298","journal-title":"Front Neurosci"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/j.1528-1157.1993.tb05918.x","volume":"34","author":"Macdonald R.L.","year":"1993","unstructured":"Macdonald R.L.; Kelly K.M.; Antiepileptic drug mechanisms of action. Epilepsia  (Suppl. 5)1993,34(s5),S1-S8","journal-title":"Epilepsia"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2165\/00023210-200115050-00001","volume":"15","author":"Czuczwar S.J.","year":"2001","unstructured":"Czuczwar S.J.; Patsalos P.N.; The new generation of GABA enhancers. Potential in the treatment of epilepsy. CNS Drugs  2001,15(5),339-350","journal-title":"CNS Drugs"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1527-3458.2003.tb00249.x","volume":"9","author":"Johannessen C.U.","year":"2003","unstructured":"Johannessen C.U.; Johannessen S.I.; Valproate: Past, present, and future. CNS Drug Rev  2003,9(2),199-216","journal-title":"CNS Drug Rev"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"5763","DOI":"10.1016\/j.bmc.2012.08.009","volume":"20","author":"Hawker D.D.","year":"2012","unstructured":"Hawker D.D.; Silverman R.B.; Synthesis and evaluation of novel heteroaromatic substrates of GABA aminotransferase. Bioorg Med Chem  2012,20(19),5763-5773","journal-title":"Bioorg Med Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"4688","DOI":"10.3390\/ijms22094688","volume":"22","author":"Salman M.M.","year":"2021","unstructured":"Salman M.M.; Al-Obaidi Z.; Kitchen P.; Loreto A.; Bill R.M.; Wade-Martins R.; Advances in applying computer-aided drug design for neurodegenerative diseases. Int J Mol Sci  2021,22(9),4688","journal-title":"Int J Mol Sci"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"FSO862","DOI":"10.2144\/fsoa-2022-0085","volume":"9","author":"Azad I.","year":"2023","unstructured":"Azad I.; Khan T.; Ahmad N.; Khan A.R.; Akhter Y.; Updates on drug designing approach through computational strategies: A review. Future Sci OA  2023,9(5),FSO862","journal-title":"Future Sci OA"},{"key":"ref=14","author":"Talluri S.","year":"2023","unstructured":"Talluri S.; Novel computational methods for cancer drug design. Curr Med Chem  2023","journal-title":"Curr Med Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.2174\/1875692116666181108145230","volume":"16","author":"Mohanasundaram N.","year":"2019","unstructured":"Mohanasundaram N.; Sekhar T.; Computational studies of molecular targets regarding the adverse effects of isoniazid drug for tuberculosis. Curr Pharmacogenomics Person Med  2019,16(3),210-218","journal-title":"Curr Pharmacogenomics Person Med"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"18699","DOI":"10.1021\/acsomega.2c01404","volume":"7","author":"Urbina F.","year":"2022","unstructured":"Urbina F.; Lowden C.T.; Culberson J.C.; Ekins S.; MegaSyn: Integrating generative molecular design, automated analog designer, and synthetic viability prediction. ACS Omega  2022,7(22),18699-18713","journal-title":"ACS Omega"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3390\/biom11060897","volume":"11","author":"Kosz\u0142a O.","year":"2021","unstructured":"Kosz\u0142a O.; St\u0119pnicki P.; Zi\u0119ba A.; Grudzi\u0144ska A.; Matosiuk D.; Kaczor A.A.; Current approaches and tools used in drug development against Parkinson\u2019s disease. Biomolecules  2021,11(6),897","journal-title":"Biomolecules"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.3390\/pharmaceutics13101542","volume":"13","author":"Neumaier F.","year":"2021","unstructured":"Neumaier F.; Zlatopolskiy B.D.; Neumaier B.; Drug penetration into the central nervous system: Pharmacokinetic concepts and in vitro model systems. Pharmaceutics  2021,13(10),1542","journal-title":"Pharmaceutics"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41597-021-01069-5","volume":"8","author":"Meng F.","year":"2021","unstructured":"Meng F.; Xi Y.; Huang J.; Ayers P.W.; A curated diverse molecular database of blood-brain barrier permeability with chemical descriptors. Sci Data  2021,8(1),289","journal-title":"Sci Data"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.2147\/DDDT.S218708","volume":"13","author":"Bagchi S.","year":"2019","unstructured":"Bagchi S.; Chhibber T.; Lahooti B.; Verma A.; Borse V.; Jayant R.D.; In-vitro blood-brain barrier models for drug screening and permeation studies: An overview. Drug Des Devel Ther  2019,13,3591-3605","journal-title":"Drug Des Devel Ther"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.bpj.2014.06.024","volume":"107","author":"Carpenter T.S.","year":"2014","unstructured":"Carpenter T.S.; Kirshner D.A.; Lau E.Y.; Wong S.E.; Nilmeier J.P.; Lightstone F.C.; A method to predict blood-brain barrier permeability of drug-like compounds using molecular dynamics simulations. Biophys J  2014,107(3),630-641","journal-title":"Biophys J"},{"key":"ref=22","first-page":"303","volume":"9","author":"Rishton G.M.","year":"2006","unstructured":"Rishton G.M.; LaBonte K.; Williams A.J.; Kassam K.; Kolovanov E.; Computational approaches to the prediction of blood-brain barrier permeability: A comparative analysis of central nervous system drugs versus secretase inhibitors for Alzheimer\u2019s disease. Curr Opin Drug Discov Devel  2006,9(3),303-313","journal-title":"Curr Opin Drug Discov Devel"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"10995","DOI":"10.3390\/ijms222010995","volume":"22","author":"Kim T.","year":"2021","unstructured":"Kim T.; You B.H.; Han S.; Shin H.C.; Chung K.C.; Park H.; Quantum artificial neural network approach to derive a highly predictive 3D-QSAR model for blood\u2013brain barrier passage. Int J Mol Sci  2021,22(20),10995","journal-title":"Int J Mol Sci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/jcc.20437","volume":"27","author":"Hemmateenejad B.","year":"2006","unstructured":"Hemmateenejad B.; Miri R.; Safarpour M.A.; Mehdipour A.R.; Accurate prediction of the blood\u2013brain partitioning of a large set of solutes using ab initio calculations and genetic neural network modeling. J Comput Chem  2006,27(11),1125-1135","journal-title":"J Comput Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.jmgm.2010.03.010","volume":"28","author":"Vilar S.","year":"2010","unstructured":"Vilar S.; Chakrabarti M.; Costanzi S.; Prediction of passive blood\u2013brain partitioning: Straightforward and effective classification models based on in silico derived physicochemical descriptors. J Mol Graph Model  2010,28(8),899-903","journal-title":"J Mol Graph Model"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1021\/acs.jcim.9b00834","volume":"60","author":"Thai N.Q.","year":"2020","unstructured":"Thai N.Q.; Theodorakis P.E.; Li M.S.; Fast estimation of the blood\u2013brain barrier permeability by pulling a ligand through a lipid membrane. J Chem Inf Model  2020,60(6),3057-3067","journal-title":"J Chem Inf Model"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"5901","DOI":"10.3390\/molecules25245901","volume":"25","author":"Radchenko E.V.","year":"2020","unstructured":"Radchenko E.V.; Dyabina A.S.; Palyulin V.A.; Towards deep neural network models for the prediction of the blood\u2013brain barrier permeability for diverse organic compounds. Molecules  2020,25(24),5901","journal-title":"Molecules"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1504\/IJCBDD.2013.052195","volume":"6","author":"Shityakov S.","year":"2013","unstructured":"Shityakov S.; Neuhaus W.; Dandekar T.; F\u00f6rster C.; Analysing molecular polar surface descriptors to predict blood-brain barrier permeation. Int J Comput Biol Drug Des  2013,6(1\/2),146-156","journal-title":"Int J Comput Biol Drug Des"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"170","DOI":"10.2174\/157340608783789103","volume":"4","author":"Zhang H.","year":"2008","unstructured":"Zhang H.; Hu S.; Zhang Y.; Prediction of distribution of neutral, acidic and basic structurally diverse compounds between blood and brain by the nonlinear methodology. Med Chem  2008,4,170-189","journal-title":"Med Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jmgm.2013.05.006","volume":"44","author":"Durrant J.D.","year":"2013","unstructured":"Durrant J.D.; Lindert S.; McCammon J.A.; AutoGrow 3.0: An improved algorithm for chemically tractable, semi-automated protein inhibitor design. J Mol Graph Model  2013,44,104-112","journal-title":"J Mol Graph Model"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"Morris G.M.","year":"2009","unstructured":"Morris G.M.; Huey R.; Lindstrom W.; Sanner M.F.; Belew R.K.; Goodsell D.S.; Olson A.J.; AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem  2009,30(16),2785-2791","journal-title":"J Comput Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"Trott O.","year":"2010","unstructured":"Trott O.; Olson A.J.; AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem  2010,31(2),455-461","journal-title":"J Comput Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","volume":"267","author":"Jones G.","year":"1997","unstructured":"Jones G.; Willett P.; Glen R.C.; Leach A.R.; Taylor R.; Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen. J Mol Biol  1997,267(3),727-748","journal-title":"J Mol Biol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.3390\/biom13111633","volume":"13","author":"Holmes S.G.","year":"2023","unstructured":"Holmes S.G.; Desai U.R.; Assessing genetic algorithm-based docking protocols for prediction of heparin oligosaccharide binding geometries onto proteins. Biomolecules  2023,13(11),1633","journal-title":"Biomolecules"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1089\/cmb.2015.0190","volume":"23","author":"Guan B.","year":"2016","unstructured":"Guan B.; Zhang C.; Ning J.; EDGA: A population evolution direction-guided genetic algorithm for protein\u2013ligand docking. J Comput Biol  2016,23(7),585-596","journal-title":"J Comput Biol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1504\/IJBRA.2019.099575","volume":"15","author":"Talluri S.","year":"2019","unstructured":"Talluri S.; Computational design of bacteriocins based on structural scaffold of Aureocin A53. J Bioinform Res Appl  2019,15,129-143","journal-title":"J Bioinform Res Appl"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.apcsb.2022.01.003","volume":"130","author":"Talluri S.","year":"2022","unstructured":"Talluri S.; Algorithms for protein design. Adv Protein Chem Struct Biol  2022,130,1-38","journal-title":"Adv Protein Chem Struct Biol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13321-020-00429-4","volume":"12","author":"Spiegel J.O.","year":"2020","unstructured":"Spiegel J.O.; Durrant J.D.; AutoGrow4: An open-source genetic algorithm for de novo drug design and lead optimization. J Cheminform  2020,12(1),25","journal-title":"J Cheminform"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"909499","DOI":"10.3389\/fmolb.2022.909499","volume":"9","author":"Pavan M.","year":"2022","unstructured":"Pavan M.; Menin S.; Bassani D.; Sturlese M.; Moro S.; Implementing a scoring function based on interaction fingerprint for autogrow4: protein kinase CK1\u03b4 as a case study. Front Mol Biosci  2022,9,909499","journal-title":"Front Mol Biosci"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"Jumper J.","year":"2021","unstructured":"Jumper J.; Evans R.; Pritzel A.; Green T.; Figurnov M.; Ronneberger O.; Tunyasuvunakool K.; Bates R.; \u017d\u00eddek A.; Potapenko A.; Bridgland A.; Meyer C.; Kohl S.A.A.; Ballard A.J.; Cowie A.; Romera-Paredes B.; Nikolov S.; Jain R.; Adler J.; Back T.; Petersen S.; Reiman D.; Clancy E.; Zielinski M.; Steinegger M.; Pacholska M.; Berghammer T.; Bodenstein S.; Silver D.; Vinyals O.; Senior A.W.; Kavukcuoglu K.; Kohli P.; Hassabis D.; Highly accurate protein structure prediction with AlphaFold. Nature  2021,596(7873),583-589","journal-title":"Nature"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1021\/ja512299n","volume":"137","author":"Lee H.","year":"2015","unstructured":"Lee H.; Doud E.H.; Wu R.; Sanishvili R.; Juncosa J.I.; Liu D.; Kelleher N.L.; Silverman R.B.; Mechanism of inactivation of \u03b3-aminobutyric acid aminotransferase by (1S,3S)-3-amino-4-difluoromethylene-1-cyclopentanoic acid (CPP-115). J Am Chem Soc  2015,137(7),2628-2640","journal-title":"J Am Chem Soc"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1093\/bioinformatics\/btv082","volume":"31","author":"Alhossary A.","year":"2015","unstructured":"Alhossary A.; Handoko S.D.; Mu Y.; Kwoh C.K.; Fast, accurate, and reliable molecular docking with QuickVina 2. Bioinformatics  2015,31(13),2214-2216","journal-title":"Bioinformatics"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"Eberhardt J.","year":"2021","unstructured":"Eberhardt J.; Santos-Martins D.; Tillack A.F.; Forli S.; AutoDock vina 1.2.0: New docking methods, expanded force field, and python bindings. J Chem Inf Model  2021,61(8),3891-3898","journal-title":"J Chem Inf Model"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","volume":"17","author":"Virtanen P.","year":"2020","unstructured":"Virtanen P.; Gommers R.; Oliphant T.E.; Haberland M.; Reddy T.; Cournapeau D.; Burovski E.; Peterson P.; Weckesser W.; Bright J.; van der Walt S.J.; Brett M.; Wilson J.; Millman K.J.; Mayorov N.; Nelson A.R.J.; Jones E.; Kern R.; Larson E.; Carey C.J.; Polat \u0130.; Feng Y.; Moore E.W.; VanderPlas J.; Laxalde D.; Perktold J.; Cimrman R.; Henriksen I.; Quintero E.A.; Harris C.R.; Archibald A.M.; Ribeiro A.H.; Pedregosa F.; van Mulbregt P.; Vijaykumar A.; Bardelli A.P.; Rothberg A.; Hilboll A.; Kloeckner A.; Scopatz A.; Lee A.; Rokem A.; Woods C.N.; Fulton C.; Masson C.; H\u00e4ggstr\u00f6m C.; Fitzgerald C.; Nicholson D.A.; Hagen D.R.; Pasechnik D.V.; Olivetti E.; Martin E.; Wieser E.; Silva F.; Lenders F.; Wilhelm F.; Young G.; Price G.A.; Ingold G-L.; Allen G.E.; Lee G.R.; Audren H.; Probst I.; Dietrich J.P.; Silterra J.; Webber J.T.; Slavi\u010d J.; Nothman J.; Buchner J.; Kulick J.; Sch\u00f6nberger J.L.; de Miranda Cardoso J.V.; Reimer J.; Harrington J.; Rodr\u00edguez J.L.C.; Nunez-Iglesias J.; Kuczynski J.; Tritz K.; Thoma M.; Newville M.; K\u00fcmmerer M.; Bolingbroke M.; Tartre M.; Pak M.; Smith N.J.; Nowaczyk N.; Shebanov N.; Pavlyk O.; Brodtkorb P.A.; Lee P.; McGibbon R.T.; Feldbauer R.; Lewis S.; Tygier S.; Sievert S.; Vigna S.; Peterson S.; More S.; Pudlik T.; Oshima T.; Pingel T.J.; Robitaille T.P.; Spura T.; Jones T.R.; Cera T.; Leslie T.; Zito T.; Krauss T.; Upadhyay U.; Halchenko Y.O.; V\u00e1zquez-Baeza Y.; SciPy 1.0: Fundamental algorithms for scientific computing in Python. Nat Methods  2020,17(3),261-272","journal-title":"Nat Methods"},{"key":"ref=45","author":"Landrum G.","year":"2024","unstructured":"Landrum G.; Tosco P.; Kelley, B rdkit\/rdkit: 2024_03_1 (Q1 2024) Release.  Available from2024"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"Daina A.","year":"2017","unstructured":"Daina A.; Michielin O.; Zoete V.; SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep  2017,7(1),42717","journal-title":"Sci Rep"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/cmdc.201600182","volume":"11","author":"Daina A.","year":"2016","unstructured":"Daina A.; Zoete V.; A BOILED-Egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem  2016,11(11),1117-1121","journal-title":"ChemMedChem"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"Pettersen E.F.","year":"2004","unstructured":"Pettersen E.F.; Goddard T.D.; Huang C.C.; Couch G.S.; Greenblatt D.M.; Meng E.C.; Ferrin T.E.; UCSF Chimera\u2014A visualization system for exploratory research and analysis. J Comput Chem  2004,25(13),1605-1612","journal-title":"J Comput Chem"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","volume":"52","author":"Knox C.","year":"2024","unstructured":"Knox C.; Wilson M.; Klinger C.M.; Franklin M.; Oler E.; Wilson A.; Pon A.; Cox J.; Chin N.E.L.; Strawbridge S.A.; Garcia-Patino M.; Kruger R.; Sivakumaran A.; Sanford S.; Doshi R.; Khetarpal N.; Fatokun O.; Doucet D.; Zubkowski A.; Rayat D.Y.; Jackson H.; Harford K.; Anjum A.; Zakir M.; Wang F.; Tian S.; Lee B.; Liigand J.; Peters H.; Wang R.Q.R.; Nguyen T.; So D.; Sharp M.; da Silva R.; Gabriel C.; Scantlebury J.; Jasinski M.; Ackerman D.; Jewison T.; Sajed T.; Gautam V.; Wishart D.S.; DrugBank 6.0: The drugbank knowledgebase for 2024. Nucleic Acids Res  2024,52(D1),D1265-D1275","journal-title":"Nucleic Acids Res"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","volume":"51","author":"Bateman A.","year":"2023","unstructured":"Bateman A.; Martin M-J.; Orchard S.; Magrane M.; Ahmad S.; Alpi E.; Bowler-Barnett E.H.; Britto R.; Bye-A-Jee H.; Cukura A.; Denny P.; Dogan T.; Ebenezer T.G.; Fan J.; Garmiri P.; da Costa Gonzales L.J.; Hatton-Ellis E.; Hussein A.; Ignatchenko A.; Insana G.; Ishtiaq R.; Joshi V.; Jyothi D.; Kandasaamy S.; Lock A.; Luciani A.; Lugaric M.; Luo J.; Lussi Y.; MacDougall A.; Madeira F.; Mahmoudy M.; Mishra A.; Moulang K.; Nightingale A.; Pundir S.; Qi G.; Raj S.; Raposo P.; Rice D.L.; Saidi R.; Santos R.; Speretta E.; Stephenson J.; Totoo P.; Turner E.; Tyagi N.; Vasudev P.; Warner K.; Watkins X.; Zaru R.; Zellner H.; Bridge A.J.; Aimo L.; Argoud-Puy G.; Auchincloss A.H.; Axelsen K.B.; Bansal P.; Baratin D.; Batista Neto T.M.; Blatter M-C.; Bolleman J.T.; Boutet E.; Breuza L.; Gil B.C.; Casals-Casas C.; Echioukh K.C.; Coudert E.; Cuche B.; de Castro E.; Estreicher A.; Famiglietti M.L.; Feuermann M.; Gasteiger E.; Gaudet P.; Gehant S.; Gerritsen V.; Gos A.; Gruaz N.; Hulo C.; Hyka-Nouspikel N.; Jungo F.; Kerhornou A.; Le Mercier P.; Lieberherr D.; Masson P.; Morgat A.; Muthukrishnan V.; Paesano S.; Pedruzzi I.; Pilbout S.; Pourcel L.; Poux S.; Pozzato M.; Pruess M.; Redaschi N.; Rivoire C.; Sigrist C.J.A.; Sonesson K.; Sundaram S.; Wu C.H.; Arighi C.N.; Arminski L.; Chen C.; Chen Y.; Huang H.; Laiho K.; McGarvey P.; Natale D.A.; Ross K.; Vinayaka C.R.; Wang Q.; Wang Y.; Zhang J.; UniProt: The Universal Protein Knowledgebase in 2023. Nucleic Acids Res  2023,51(D1),D523-D531","journal-title":"Nucleic Acids Res"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"Berman H.M.","year":"2000","unstructured":"Berman H.M.; Westbrook J.; Feng Z.; Gilliland G.; Bhat T.N.; Weissig H.; Shindyalov I.N.; Bourne P.E.; The protein data bank. Nucleic Acids Res  2000,28(1),235-242","journal-title":"Nucleic Acids Res"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1021\/acs.chemrev.8b00009","volume":"118","author":"Silverman R.B.","year":"2018","unstructured":"Silverman R.B.; Design and mechanism of GABA aminotransferase inactivators. Treatments for epilepsies and addictions. Chem Rev  2018,118(7),4037-4070","journal-title":"Chem Rev"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.ebiom.2019.04.059","volume":"43","author":"Lieb A.","year":"2019","unstructured":"Lieb A.; Weston M.; Kullmann D.M.; Designer receptor technology for the treatment of epilepsy. EBioMedicine  2019,43,641-649","journal-title":"EBioMedicine"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2174\/0118715249267700231116053516","volume":"24","author":"Grover S.","year":"2024","unstructured":"Grover S.; Narang R.K.; Singh S.; GABA transaminase: A key player and potential therapeutic target for neurological disorders. Cent Nerv Syst Agents Med Chem  2024,24(1),57-67","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1517\/17460441.2016.1154840","volume":"11","author":"\u0141ukawski K.","year":"2016","unstructured":"\u0141ukawski K.; Gryta P.; \u0141uszczki J.; Czuczwar S.J.; Exploring the latest avenues for antiepileptic drug discovery and development. Expert Opin Drug Discov  2016,11(4),369-382","journal-title":"Expert Opin Drug Discov"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"730257","DOI":"10.3389\/fphar.2021.730257","volume":"12","author":"L\u00f6scher W.","year":"2021","unstructured":"L\u00f6scher W.; Single-target versus multi-target drugs versus combinations of drugs with multiple targets: Preclinical and clinical evidence for the treatment or prevention of epilepsy. Front Pharmacol  2021,12,730257","journal-title":"Front Pharmacol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fchem.2020.00093","volume":"8","author":"de Souza Neto L.R.","year":"2020","unstructured":"de Souza Neto L.R.; Moreira-Filho J.T.; Neves B.J.; Maidana R.L.B.R.; Guimar\u00e3es A.C.R.; Furnham N.; Andrade C.H.; Silva F.P.; In silico strategies to support fragment-to-lead optimization in drug discovery. Front Chem  2020,8,93","journal-title":"Front Chem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.3390\/ijms22041676","volume":"22","author":"Mouchlis V.D.","year":"2021","unstructured":"Mouchlis V.D.; Afantitis A.; Serra A.; Fratello M.; Papadiamantis A.G.; Aidinis V.; Lynch I.; Greco D.; Melagraki G.; Advances in de novo drug design: From conventional to machine learning methods. Int J Mol Sci  2021,22(4),1676","journal-title":"Int J Mol Sci"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1007\/s11030-021-10326-z","volume":"26","author":"Selvaraj C.","year":"2022","unstructured":"Selvaraj C.; Chandra I.; Singh S.K.; Artificial intelligence and machine learning approaches for drug design: Challenges and opportunities for the pharmaceutical industries. Mol Divers  2022,26(3),1893-1913","journal-title":"Mol Divers"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13321-022-00598-4","volume":"14","author":"Lu C.","year":"2022","unstructured":"Lu C.; Liu S.; Shi W.; Yu J.; Zhou Z.; Zhang X.; Lu X.; Cai F.; Xia N.; Wang Y.; Systemic evolutionary chemical space exploration for drug discovery. J Cheminform  2022,14(1),19","journal-title":"J Cheminform"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s40478-020-00953-2","volume":"8","author":"Guntner A.S.","year":"2020","unstructured":"Guntner A.S.; Peyrl A.; Mayr L.; Englinger B.; Berger W.; Slavc I.; Buchberger W.; Gojo J.; Cerebrospinal fluid penetration of targeted therapeutics in pediatric brain tumor patients. Acta Neuropathol Commun  2020,8(1),78","journal-title":"Acta Neuropathol Commun"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"4888","DOI":"10.1016\/j.bmc.2006.03.012","volume":"14","author":"Katritzky A.R.","year":"2006","unstructured":"Katritzky A.R.; Kuanar M.; Slavov S.; Dobchev D.A.; Fara D.C.; Karelson M.; Acree W.E.; Solov\u2019ev V.P.; Varnek A.; Correlation of blood\u2013brain penetration using structural descriptors. Bioorg Med Chem  2006,14(14),4888-4917","journal-title":"Bioorg Med Chem"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"6233","DOI":"10.1021\/jm901036q","volume":"52","author":"Frid\u00e9n M.","year":"2009","unstructured":"Frid\u00e9n M.; Winiwarter S.; Jerndal G.; Bengtsson O.; Wan H.; Bredberg U.; Hammarlund-Udenaes M.; Antonsson M.; Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids. J Med Chem  2009,52(20),6233-6243","journal-title":"J Med Chem"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s11030-018-9866-8","volume":"22","author":"Zhu L.","year":"2018","unstructured":"Zhu L.; Zhao J.; Zhang Y.; Zhou W.; Yin L.; Wang Y.; Fan Y.; Chen Y.; Liu H.; ADME properties evaluation in drug discovery: In silico prediction of blood\u2013brain partitioning. Mol Divers  2018,22(4),979-990","journal-title":"Mol Divers"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s10822-011-9478-1","volume":"25","author":"Muehlbacher M.","year":"2011","unstructured":"Muehlbacher M.; Spitzer G.M.; Liedl K.R.; Kornhuber J.; Qualitative prediction of blood\u2013brain barrier permeability on a large and refined dataset. J Comput Aided Mol Des  2011,25(12),1095-1106","journal-title":"J Comput Aided Mol Des"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"18279","DOI":"10.3390\/molecules201018279","volume":"20","author":"Naef R.","year":"2015","unstructured":"Naef R.; A generally applicable computer algorithm based on the group additivity method for the calculation of seven molecular descriptors: Heat of combustion, LogPO\/W, LogS, refractivity, polarizability, toxicity and logbb of organic compounds; Scope and limits of applicability. Molecules  2015,20(10),18279-18351","journal-title":"Molecules"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"105943","DOI":"10.1016\/j.cmpb.2021.105943","volume":"200","author":"Wu Z.","year":"2021","unstructured":"Wu Z.; Xian Z.; Ma W.; Liu Q.; Huang X.; Xiong B.; He S.; Zhang W.; Artificial neural network approach for predicting blood brain barrier permeability based on a group contribution method. Comput Methods Programs Biomed  2021,200,105943","journal-title":"Comput Methods Programs Biomed"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"4582","DOI":"10.1021\/acs.jcim.0c00517","volume":"60","author":"Domenico A.","year":"2020","unstructured":"Domenico A.; Nicola G.; Daniela T.; Fulvio C.; Nicola A.; Orazio N.; De Novo drug design of targeted chemical libraries based on artificial intelligence and pair-based multiobjective optimization. J Chem Inf Model  2020,60(10),4582-4593","journal-title":"J Chem Inf Model"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.3390\/biom14101330","volume":"14","author":"Vicidomini C.","year":"2024","unstructured":"Vicidomini C.; Fontanella F.; D\u2019Alessandro T.; Roviello G.N.; A survey on computational methods in drug discovery for neurodegenerative diseases. Biomolecules  2024,14(10),1330-1355","journal-title":"Biomolecules"}],"container-title":["Central Nervous System Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715249385792250709073502","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/243598\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715249385792250709073502","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T10:34:56Z","timestamp":1785753296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/243598\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0118715249385792250709073502","relation":{"has-preprint":[{"id-type":"doi","id":"10.26434\/chemrxiv-2024-bfgk0","asserted-by":"object"}]},"ISSN":["1871-5249"],"issn-type":[{"value":"1871-5249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-01-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}